MDCalc

RIETE Score for Risk of Hemorrhage in Pulmonary Embolism Treatment

Determine the risk of major bleeding during anticoagulant therapy.

Recent major bleeding

Creatinine >1.2 mg/dL (106 µmol/L)

Anemia
Hgb <13 g/dL for men, Hgb <12 g/dL for women
Malignancy history
Clinically-overt pulmonary embolism
Patients who were evaluated for PE and PE diagnosed, NOT incidental PE found during other studies
Age >75

Result:

Please fill out required fields.
Critical Actions
  • Risks and benefits of anti-coagulation should be carefully considered in ALL patients prior to initiating therapy
  • Alternative options should often be considered in patients with high-risk of major bleeding events in need of anti-coagulation